Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Pediatr Diabetes. 2019 May 23;20(6):759–768. doi: 10.1111/pedi.12867

TABLE 1.

Demographics characteristics of the participants

Site
CA
CO
VA
Overall cohort
Study arm RM-SAP Control-IQ RM-SAP Control-IQ RM-SAP Control-IQ RM-SAP Control-IQ
Number N = 6 N = 6 N = 6 N = 6 N = 12 N = 12 24 24
Gender (% female) 50 50 50 50 54 46 54 46
Age (years) 9.7 ± 1.4 10.8 ± 2.4 8.8 ± 0.4 9.2 ± 1.6 14.8 ± 1.8 15.0 ± 1.4 12.0 ± 3.2 12.5 ± 3.1
Height (cm) 138.4 ± 13 4 143.9 ± 12 136.5 ± 2.4 137.9 ± 8.9 168.9 ± 8.7 166.6 ± 10.2 153.2 ± 18.8 153.8 ± 16.6
Weight (kg) 36.7 ± 4.4 41.2 ± 9.2 31 ± 3.1 36.5 ± 10.7 73.6 ± 16.8 60.1 ± 10.9 53.7 ± 24.2 49.5 ± 14.2
BMI (kg/m2) 18.9 ± 0.8 19.6 ± 1.5 16.6 ± 1.6 18.9 ± 3.8 25.7 ± 4.7 21.5 ± 2.4 21.7 ± 5.7 20.4 ± 2.8
Diabetes duration (years) 4.0 ± 0.7 4.7 ± 0.2 4.8 ± 1.6 4.7 ± 2.8 5.6 ± 2.4 6.7 ± 3.2 5.0 ± 2.0 5.7 ± 2.9
Pump use (years) 3.3 ± 0.7 4.2 ± 1.7 3.7 ± 2.0 4 ± 2.3 4.9 ± 2.1 6.5 ± 3.5 4.2 ± 2.0 5.3 ± 3.0
Daily insulin dose (U/kg) 0.7 ± 0.0 0.8 ± 0.1 0.7 ± 0.2 0.7 ± 0.3 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2
Glycated hemoglobin (%) 7.2 ± 0.3 7.4 ± 0.7 7.6 ± 0.7 7.3 ± 0.8 8.0 ± 1.1 8.3 ± 1.5 7.7 ± 0.9 7.8 ± 1.3